Ofatumumab‐associated acute pneumonitis: Not new but still the first case

Ofatumumab is an anti‐CD20 humanized monoclonal antibody utilized in the treatment of several clinical conditions resistant to other treatments. In spite there was a general expectation that ofatumumab was less toxic compared to rituximab, side effects have been reported that resemble those of its a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonanni, Alice, Bertelli, Enrica, Panicucci, Chiara, D'Alessandro, Matteo, Moscatelli, Andrea, Lampugnani, Elisabetta, Sacco, Oliviero, Magnano, Gian Michele, Ravani, Pietro, Ghiggeri, Gian Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461639/
https://www.ncbi.nlm.nih.gov/pubmed/28596831
http://dx.doi.org/10.1002/prp2.267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461639/
https://www.ncbi.nlm.nih.gov/pubmed/28596831
http://dx.doi.org/10.1002/prp2.267

Ejemplares similares